Source link : https://www.newshealth.biz/health-news/wegovy-perks-sustained-for-years-most-have-ckm-syndrome-new-adrenal-guidelines/
One in eight U.S. adults have taken semaglutide (Ozempic, Wegovy) or another GLP-1 agonist, a KFF poll found. Metabolic benefits of semaglutide for weight loss were sustained for several years, according to findings presented at the European Congress on Obesity. In people with overweight or obesity without diabetes, semaglutide yielded an average 10.2% weight loss […]
Author : News Health
Publish date : 2024-05-14 16:15:05
Copyright for syndicated content belongs to the linked Source.
Categories